Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates

Published on September 10, 2024
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates

New assays based on iPSC help accelerate drug discovery by giving drug innovators in neurodegenerative diseases high quality data on a broad range of disease-relevant read-outs

Continue reading on website
Other news

Pharma outlook: From uncertainty to predictability

September 9, 2024
Change is the only constant in the pharmaceuticals industry. There have been many paradigm shifts driven by specific therapies, like AIDS in the 1990s and the COVID-19 vaccine in 2020, and some believe that the recent rise of obesity and diabetes drugs to be potentially the biggest of all. That said, it may be that […]

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024

September 10, 2024
DENVER, Sept. 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE),